Empirical Bio

Empirical Bio is a London-based company founded in 2024 that develops machine learning software for predicting and optimizing the structures of enzymes and other biomolecules, with the aim of letting biotech research teams shortlist candidates computationally and reduce the number of laboratory testing cycles required. The company appears in the Entrepreneurs First portfolio directory, which indexes companies by location, industry, founding year and funding stage.

As of the material reviewed, the company's public web presence is minimal: its website at empirical.sh consists of a placeholder page marked "Launching Soon" with an email sign-up form for updates, carrying a 2024 copyright notice. No product documentation, customer references, pricing, team page or funding disclosures are available on the public site.

Note on name twins: several sources retrieved under similar names refer to Empirical Bioscience, Inc., a US developer and manufacturer of enzymes, proteins and reagents acquired by Fortis Life Sciences. That is a distinct company and its facts are not included in this profile.

Traction

No traction metrics, customers, partnerships or funding amounts are disclosed in the available sources.

Latest developments

The company's website was, at the time of retrieval, a pre-launch placeholder stating "Launching Soon" and collecting email addresses for future updates, indicating the product had not yet been publicly released.